Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Adial Pharmaceuticals (ADIL) Interest Expenses (2023 - 2024)

Adial Pharmaceuticals' Interest Expenses history spans 2 years, with the latest figure at $1.0 for Q2 2024.

  • For Q2 2024, Interest Expenses fell 100.0% year-over-year to $1.0; the TTM value through Dec 2024 reached $43.0, down 99.92%, while the annual FY2018 figure was $1.2 million, 707.44% up from the prior year.
  • Interest Expenses for Q2 2024 was $1.0 at Adial Pharmaceuticals, down from $42.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $37901.0 in Q2 2023 and bottomed at $1.0 in Q2 2024.